The UCI is enhancing anti-doping measures for the 2025 Tour de France by collaborating with the International Testing Agency (ITA) to integrate data-driven methods with traditional testing. As part of this plan, the ITA will increase urine and blood tests, utilizing longitudinal analysis of biological data to identify performance-enhancing drugs. The initiative aims to strengthen controls and ensure compliance, including testing procedures for event leaders and random tests throughout the competition. The goal is to maintain integrity in cycling through rigorous and sophisticated testing protocols.
The UCI's plan for the 2025 Tour de France will involve the ITA utilizing data-driven methods alongside traditional anti-doping controls to ensure fairness in the competition.
With enhanced investigative powers, the ITA has expanded its resources devoted to cycling, focusing on longitudinal analysis to detect harder-to-trace performance enhancers.
Collection
[
|
...
]